Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) Research & Development (2016 - 2025)

Milestone Scientific (MLSS) has disclosed Research & Development for 16 consecutive years, with $12334.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 94.33% to $12334.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $449469.0 through Dec 2025, down 47.66% year-over-year, with the annual reading at $449469.0 for FY2025, 47.66% down from the prior year.
  • Research & Development hit $12334.0 in Q4 2025 for Milestone Scientific, down from $16226.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $464466.0 in Q1 2022 to a low of $12334.0 in Q4 2025.
  • Historically, Research & Development has averaged $201901.6 across 5 years, with a median of $214533.5 in 2021.
  • Biggest five-year swings in Research & Development: skyrocketed 2724.53% in 2022 and later plummeted 94.33% in 2025.
  • Year by year, Research & Development stood at $290167.0 in 2021, then dropped by 12.81% to $252991.0 in 2022, then crashed by 30.07% to $176906.0 in 2023, then rose by 22.96% to $217532.0 in 2024, then tumbled by 94.33% to $12334.0 in 2025.
  • Business Quant data shows Research & Development for MLSS at $12334.0 in Q4 2025, $16226.0 in Q3 2025, and $51789.0 in Q2 2025.